Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 22, 2013- EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus® -
-
Jun 22, 2013-- Lixisenatide decreased HbA1c by reducing PPG when added to basal insulin with or without oral anti-diabetic agents --
-
May 16, 2013- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action -
-
May 6, 2013The same trusted formula in an easy aim spray
-
May 6, 2013-Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views-
-
Mar 21, 2013National Patient Spokesperson Melanie Bloom Commemorates Significant Achievements to Raise Awareness of DVT and Potentially Fatal Complication, Pulmonary Embolism
-
Jan 29, 2013--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels--
-
Aug 13, 2012-- Breakthrough device design talks patients and caregivers through the injection process --
-
Jun 11, 2012- No increased risk of cancer found with Lantus® in new European and U.S. observational studies -
-
Jun 9, 2012- Lixisenatide with basal insulin helped type 2 diabetes patients with uncontrolled HbA1c achieve target blood glucose levels -
-
May 2, 2012- First FDA Cleared Blood Glucose Meter that Connects Directly to iPhone® and iPod touch® -
-
Apr 24, 2012Birmingham Program to Improve Diabetes Management through Behavioral Economics
-
Mar 7, 2012Fewer Than One in Three Survey Participants Discussed DVT/PE with Healthcare Professional
-
Feb 7, 2012-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --
-
Nov 16, 2011Local Demonstration Program to Implement Community-Based Diabetes Management Announced
-
Nov 11, 2011Sanofi Collaborates with Leading Health Organizations to Help Men Take More Proactive Stance in Managing Their Disease
-
Oct 5, 2011- Findings from Two-Year Pivotal Phase III TEMSO Trial Published today in The New England Journal of Medicine -
-
Oct 3, 2011Nationwide Recipe Contest Elevates Awareness for Proper Diabetes Management
-
Sep 27, 2011AFib Educator 2.0" Includes New Animations, Resources to Improve Patient-Physician Dialogue
-
Sep 13, 2011National AFib Education Campaign Launches to Help Improve the Care of People with This Serious and Increasingly Prevalent(1) Form of Irregular Heartbeat
-
Sep 12, 2011- Weight gain was lowest in patients with baseline A1C below 8 percent and in patients 65 years and older -
-
Sep 12, 2011- New phase III data from GetGoal-F1 study of once-daily lixisenatide support simplified treatment initiation -
-
Jun 7, 2011Diabetes Co-Stars: Cook-Off Invites People to Share Diabetes-Friendly Recipes
-
Jun 4, 2011- Results of Phase III SAVE-ONCO study selected for "Best of ASCO 2011" -
-
Mar 22, 2011"AFib in America: State Impact Reports" Illustrate the Disconnect Between AFib's Impact and the Public Health Resources Available
-
Mar 9, 2011The Coalition to Prevent DVT Promotes Education to Fill the Gap between DVT Risk and Co-Morbid Patients
-
Dec 9, 2010Final 10-year combination chemotherapy adjuvant survival data, studies of investigational agent iniparib to be featured at breast cancer symposium
-
Oct 1, 2010- Results of the Phase III TROPIC global study published -
-
Sep 22, 2010Repeated Doctors Visits, ER Trips, and Admissions to Inpatient/Outpatient Facilities Create High Costs for Managing Patients with a Common, Complex Cardiovascular Disease
-
Sep 21, 2010-'Diabetes Co-Stars' Offers Information and Support to People Living with Diabetes, Family and Friends -
-
Sep 20, 2010- Findings Presented at European Association for the Study of Diabetes (EASD) 46th Annual Meeting -
-
Sep 20, 2010- Phase III Study Results also demonstrated the therapy had acceptable safety profile -
-
Jun 26, 2010- Study Findings Presented at American Diabetes Association's 70th Annual Scientific Sessions -
-
Jun 17, 2010- First and only therapy to provide significant survival benefit in second-line metastatic hormone-refractory prostate cancer -
-
Apr 1, 2010Interactive Exhibit Unveiled at New Jersey's Liberty Science Center as it Embarks on Three-Year, 12-City Tour
-
Mar 3, 2010- Results observed in patients treated with cabazitaxel plus prednisone whose disease progressed despite prior docetaxel-based chemotherapy -